Literature DB >> 15948217

Distribution and phenotype of murine rotavirus-specific B cells induced by intranasal immunization with 2/6 virus-like particles.

Agathe Ogier1, Manuel A Franco, Annie Charpilienne, Jean Cohen, Pierre Pothier, Evelyne Kohli.   

Abstract

Virus-like particles containing the rotavirus (RV) internal proteins VP2 and VP6 (2/6-VLP) have been shown to induce serum and fecal antibodies as well as protection in mice after intranasal administration with a mutant of E. coli toxin, LT-R192G. To better understand the origin of fecal IgA induced by this protocol, we studied the RV-specific B cell response in systemic and mucosal lymphoid tissues using a flow cytometry assay that allows quantification and phenotypic characterization of RV-specific B lymphocytes. We also assessed the RV-specific antibody-secreting cells in the spleen and intestinal lamina propria (ILP). A remarkably high frequency of RV-specific B cells was found in the respiratory lymphoid tissues and spleen, of which only a minority expressed the alpha4beta7 integrin (intestinal homing receptor). In contrast, but in accordance with alpha4beta7 expression at the induction site, a very low response was observed in intestinal lymphoid tissues (mesenteric lymph nodes and ILP), which did not increase after a second immunization. Thus, intranasal immunization with a nonreplicating antigen does not induce an important number of RV-specific B cells with an intestinal homing profile.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15948217     DOI: 10.1002/eji.200526059

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

1.  Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.

Authors:  Nathalie Parez; Cynthia Fourgeux; Ali Mohamed; Catherine Dubuquoy; Mathieu Pillot; Axelle Dehee; Annie Charpilienne; Didier Poncet; Isabelle Schwartz-Cornil; Antoine Garbarg-Chenon
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

2.  Intrarectal immunization with rotavirus 2/6 virus-like particles induces an antirotavirus immune response localized in the intestinal mucosa and protects against rotavirus infection in mice.

Authors:  Davide Agnello; Christine A Hervé; Amandine Lavaux; Magali Darniot; Patrice Guillon; Annie Charpilienne; Pierre Pothier
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

Review 3.  Immunity to enteric viruses.

Authors:  Ainsley Lockhart; Daniel Mucida; Roham Parsa
Journal:  Immunity       Date:  2022-05-10       Impact factor: 43.474

4.  Development of a Bacillus subtilis-based rotavirus vaccine.

Authors:  Sangun Lee; Boris R Belitsky; James P Brinker; Kathryn O Kerstein; David W Brown; John D Clements; Gerald T Keusch; Saul Tzipori; Abraham L Sonenshein; John E Herrmann
Journal:  Clin Vaccine Immunol       Date:  2010-09-01

Review 5.  Cholera-like enterotoxins and Regulatory T cells.

Authors:  Christelle Basset; Fatou Thiam; Cyrille Di Martino; John Holton; John D Clements; Evelyne Kohli
Journal:  Toxins (Basel)       Date:  2010-07-06       Impact factor: 4.546

6.  Unexpected modulation of recall B and T cell responses after immunization with rotavirus-like particles in the presence of LT-R192G.

Authors:  Fatou Thiam; Cyrille Di Martino; Fabienne Bon; Annie Charpilienne; Claire Cachia; Didier Poncet; John D Clements; Christelle Basset; Evelyne Kohli
Journal:  Toxins (Basel)       Date:  2010-08-05       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.